Vitae Pharmaceuticals Company Profile

23:38 EDT 25th May 2015 | BioPortfolio

Vitae Pharmaceuticals is an emerging pharmaceutical company with two compounds in human clinical trials, a broad portfolio of late stage preclinical programs and an underlying pipeline of discovery programs. Vitae's goal is to discover, develop and commercialize innovative new medicines that will be best-in-class for important disease areas, such as cardiovascular diseases, cancer and dermatology.We are focused on the development of compounds for high value, well validated biological targets. In our discovery and development processes, we seek to leverage available existing clinical and / or preclinical knowledge to efficiently and effectively create novel drug candidates that can address clear unmet therapy needs. Vitae's unique product engine combines the drug discovery skills of proven, deeply experienced drug hunters with state-of-the-art proprietary drug design technologies. This integrated and entrepreneurial approach improves the quality and innovativeness of the compounds we discover, while dramatically shortening the time required to bring them to the clinic.We have demonstrated the ability to rapidly advance novel compounds into clinical development, as Vitae now has clinical candidates in three therapeutic areas, two of which are in clinical studies and a pipeline of additional promising compounds.

Location

502 West Office Center
Drive Fort Washington
Pennsylvania
19034
United States of America

Contact

Phone: (215) 461-2000
Fax: (215) 461-2006
Email: contact@vitaepharma.com


News Articles [30 Associated News Articles listed on BioPortfolio]

Vitae Pharmaceuticals Q1 Results

Vitae Pharmaceuticals, Inc., a clinical-stage biotechnology company developing a robust and growing portfolio generated by its proprietary structure-based drug discovery platform, reported today its o...

Vitae nets $33.6mm via FOPO

In its first FOPO since going public four months ago, Vitae Pharmaceuticals Inc. (developed the Contour structure-based drug discovery platform) netted $33.6mm through the follow-on public offering of...

Vitae nets $38.6mm via FOPO

In its first FOPO since going public four months ago, Vitae Pharmaceuticals Inc. (developed the Contour structure-based drug discovery platform) netted $38.6mm through the follow-on public offering of...

New Vitae Wellness and Recovery to Host Booth at Quakertown Arts Alive!

Quakertown, PA, May 13, 2015 --(PR.com)-- Date: May 16, 2015 Time: 10 a.m. – 4 p.m. Location: 117 W. Broad Street, Quakertown, Pa 18951 (Note: No vehicle access to this location) Details: In...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE

NEW YORK, Feb. 27, 2015 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vitae Pharmaceuticals, Inc. ("Vitae" or the "Company") (NASDAQ: VTAE).  Such investors...

Vitae proposes follow-on

Vitae completes follow-on

Vitae Pharmaceuticals to Present at Upcoming Meetings

FORT WASHINGTON, Pa., May 6, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical-stage biotechnology company developing a robust and growing portfolio generated by its prop...

Drugs and Medications [0 Results]

None

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

The Curriculum Vitae: Gateway to Academia.

The physiologist Ewald Hering (1834-1918): Curriculum vitae.

The physiologist Ewald Hering (1834-1918): Curriculum vitae.

Scholarly productivity for nursing clinical track faculty.

Recent years have yielded substantial advancement by clinical track faculty in cohort expansion and collective contributions to the discipline of nursing. As a result, standards for progression and pr...

Preparing for Fellowship in Internal Medicine: Steps for Success with a Focus on Pulmonary and/or Critical Care Programs.

This paper outlines specific tips for those applying to pulmonary and/or critical care medicine fellowship training in the United States utilizing the PAIR-Match steps: Preparation, Application, Inter...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)

The aim of the study is to evaluate toxicity and effectiveness of electrochemotherapy with bleomycin in treatment of primary liver tumors in clinical study phase I and II. The study will ...

Companies [7 Associated Companies listed on BioPortfolio]

Vitae Pharmaceuticals, Inc.

Vitae Pharmaceuticals is a development-stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large markets, including...

Vitae Pharmaceuticals

Vitae Pharmaceuticals is an emerging pharmaceutical company with two compounds in human clinical trials, a broad portfolio of late stage preclinical programs and an underlying pipeline of discovery pr...

CV Index

The CV Index provides a permanent, web presence & management centre for your Curriculum Vitae (Resume), which is freely searchable on our powerful CVs search engine, wherever you are in the world. Ch...

BB MEDTECH's

Our Profile represents an introductory overview of the key facts investors need to know about BB MEDTECH. The various ticker symbols are also available here. Click on Board of Directors and Management...

BitTech, Inc

BitTech, Inc. is a biotechnology company that focuses on the identification and initiation of research which has the potential to lead to enabling technology. BitTech was founded by Grant A. Bitter, ...

More Information about "Vitae Pharmaceuticals" on BioPortfolio

We have published hundreds of Vitae Pharmaceuticals news stories on BioPortfolio along with dozens of Vitae Pharmaceuticals Clinical Trials and PubMed Articles about Vitae Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vitae Pharmaceuticals Companies in our database. You can also find out about relevant Vitae Pharmaceuticals Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topics

Alzheimer's Disease
Latest News Clinical Trials Research Drugs Reports Corporate
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Cardiology
Latest News Clinical Trials Research Drugs Reports Corporate
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record